Burden of non-motor symptoms of Parkinson's disease: cost-of-illness and quality-of-life estimates through a scoping review [0.03%]
帕金森病非运动症状的疾病负担：通过系统回顾估计疾病的费用和生活质量的影响
Frank van der Meer,Jesper Jorgensen,Mickael Hiligsmann
Frank van der Meer
Introduction: Parkinson's Disease (PD) is a progressive, chronic neurodegenerative disease, representing significant economic and social burdens. It is typically defined by motor symptoms (MSs), however, this does not ref...
Direct healthcare costs for people with cerebral palsy in the Brazilian unified health system between 2015 and 2019 [0.03%]
2015至2019年巴西全民卫生系统中脑瘫患者的直接医疗费用
Emilie Batista Freire,Henry Maia Peixoto,Kênnea Martins Almeida Ayupe et al.
Emilie Batista Freire et al.
Background: Estimate the costs of inpatient and outpatient care for people with Cerebral Palsy (CP) in Brazil. Research design and methods: ...
The utility and impact of digital endpoints for improving breast cancer outcomes [0.03%]
数字化终点改善乳腺癌预后的实用性和影响
Ismail Jatoi,Jonathan A L Gelfond
Ismail Jatoi
Introduction: In breast cancer clinical trials utilizing digital endpoints, wearable sensors record participants' health information during activities of daily living. These sensors are worn on the wrist or finger, placed...
Cost-effectiveness analysis of tofacitinib for the treatment of moderate to severe rheumatoid arthritis: a systematic review and meta-analysis [0.03%]
托法替尼治疗中重度类风湿性关节炎的 cost-effectiveness分析：系统回顾和荟萃分析
Behzad Fatemi,Neda Yaghoubi,Nikta Shobeiri et al.
Behzad Fatemi et al.
Background: As rheumatoid arthritis (RA) is a chronic and progressive disease that requires lifelong therapeutic intervention, it represents a considerable economic burden on those affected. This study investigated whethe...
Economic burden of suicides and suicide attempts in low- and middle-income countries: a systematic review of costing studies [0.03%]
中低收入国家自杀及自杀企图的经济负担：费用研究的系统评价
Nikhil Jain,Ben Wijnen,Isha Lohumi et al.
Nikhil Jain et al.
Introduction: Suicide is a major public health concern in low- and middle-income countries (LMICs) due to its substantial psychological, social, and economic impact. There is little synthesized evidence to estimate the ec...
Next-generation sequencing in oncology: challenges in economic evaluations [0.03%]
下一代测序在肿瘤学中的经济评估挑战
Morgan Ehman,Jesman Punian,Deirdre Weymann et al.
Morgan Ehman et al.
Introduction: Next-generation sequencing (NGS) identifies genetic variants to inform personalized treatment plans. Insufficient evidence of cost-effectiveness impedes the integration of NGS into routine cancer care. The c...
The cost-utility analysis of adding ocrelizumab to the treatment plan for primary progressive multiple sclerosis in Iran [0.03%]
奥瑞珠单抗用于伊朗初发进展型多发性硬化治疗的代价效益分析
Ali Darvishi,Ramin Abdi Dezfouli,Zohreh Ghasemian et al.
Ali Darvishi et al.
Background: This study evaluates the cost-effectiveness of adding ocrelizumab to supportive care for primary progressive multiple sclerosis (PPMS) in Iran. ...
Public value judgments about the criteria for reimbursement of medicines in South Korea [0.03%]
韩国关于药品报销标准的公共价值判断
Kyung-Bok Son
Kyung-Bok Son
Objectives: This study quantified the public value (PV) of the criteria and sub-criteria in the current drug reimbursement systems in South Korea and examined sociodemographic factors that associated with PV. ...
Charlotte Sauter,Jacob Diemar,Viktorija Terebaite
Charlotte Sauter
Acceptability and willingness to pay for a hypothetical HIV vaccine in Brazil and the implications: a cross-sectional study [0.03%]
巴西针对一种假设的艾滋病毒疫苗的接受度及支付意愿的横断面研究及其影响
Vinícius Gonçalves Nogueira,Edna Afonso Reis,Brian Godman et al.
Vinícius Gonçalves Nogueira et al.
Introduction: The Human Immunodeficiency Virus (HIV) is one of the greatest public health challenges still facing communities worldwide, and until this moment, no vaccine is available for its prevention. In Brazil, the Ri...